Cargando…

Trichosanthin enhances sensitivity of non-small cell lung cancer (NSCLC) TRAIL-resistance cells

Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) has a specific antitumour activity against many malignant tumours. However, more than half of lung cancer cells are resistant to TRAIL-relevant drugs. Trichosanthin (TCS) is a traditional Chinese medicine with strong inhibitive effects...

Descripción completa

Detalles Bibliográficos
Autores principales:	You, Chengcheng, Sun, Yingming, Zhang, Shiyu, Tang, Guiliang, Zhang, Nannan, Li, Chunyang, Tian, Xiaoli, Ma, Shijing, Luo, Yuan, Sun, Wenjie, Wang, Feng, Liu, Xuefeng, Xiao, Yu, Gong, Yan, Zhang, Junhong, Xie, Conghua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5821042/ https://www.ncbi.nlm.nih.gov/pubmed/29483839 http://dx.doi.org/10.7150/ijbs.22811

Ejemplares similares

MFP-FePt-GO Nanocomposites Promote Radiosensitivity of Non-Small Cell Lung Cancer Via Activating Mitochondrial-Mediated Apoptosis and Impairing DNA Damage Repair
por: Peng, Shan, et al.
Publicado: (2020)

Protective Role of Nuclear Factor-Erythroid 2-Related Factor 2 Against Radiation-Induced Lung Injury and Inflammation
por: Tian, Xiaoli, et al.
Publicado: (2018)

Small Nucleolar RNA 71A Promotes Lung Cancer Cell Proliferation, Migration and Invasion via MAPK/ERK Pathway
por: Tang, Guiliang, et al.
Publicado: (2019)

FePt/GO Nanosheets Suppress Proliferation, Enhance Radiosensitization and Induce Autophagy of Human Non-Small Cell Lung Cancer Cells
por: Ma, Shijing, et al.
Publicado: (2019)

MUC3A promotes non-small cell lung cancer progression via activating the NFκB pathway and attenuates radiosensitivity
por: Sun, Yingming, et al.
Publicado: (2021)

MUC3A promotes non-small cell lung cancer progression via activating the NFκB pathway and attenuates radiosensitivity
por: Sun, Yingming, et al.
Publicado: (2022)

Downregulation of Nitric Oxide Collaborated with Radiotherapy to Promote Anti-Tumor Immune Response via Inducing CD8+ T Cell Infiltration
por: Xu, Jieyu, et al.
Publicado: (2020)

MUC3A induces PD-L1 and reduces tyrosine kinase inhibitors effects in EGFR-mutant non-small cell lung cancer
por: Luo, Yuan, et al.
Publicado: (2021)

The anti-cancerous activity of recombinant trichosanthin on prostate cancer cell PC3
por: Li, JinLong, et al.
Publicado: (2016)

Comparative Proteomic Analysis of Drug Trichosanthin Addition to BeWo Cell Line
por: Hu, Yajun, et al.
Publicado: (2022)

Recent Progress of Nanoscale Metal-Organic Frameworks in Cancer Theranostics and the Challenges of Their Clinical Application
por: Sun, Wenjie, et al.
Publicado: (2019)

Trichosanthin cooperates with Granzyme B to restrain tumor formation in tongue squamous cell carcinoma
por: Zhu, Zeyao, et al.
Publicado: (2021)

Recombinant cell-penetrating trichosanthin synergizes anti-PD-1 therapy in colorectal tumor
por: Zhang, Meng, et al.
Publicado: (2023)

Trichosanthin Inhibits Breast Cancer Cell Proliferation in Both Cell Lines and Nude Mice by Promotion of Apoptosis
por: Fang, Evandro Fei, et al.
Publicado: (2012)

Trichosanthin inhibits cervical cancer by regulating oxidative stress-induced apoptosis
por: Zhu, Chenglu, et al.
Publicado: (2021)

Anti-HIV Agent Trichosanthin Enhances the Capabilities of Chemokines to Stimulate Chemotaxis and G Protein Activation, and This Is Mediated through Interaction of Trichosanthin and Chemokine Receptors
por: Zhao, Jian, et al.
Publicado: (1999)

HHLA2 deficiency inhibits non‐small cell lung cancer progression and THP‐1 macrophage M2 polarization
por: Sun, Wenjie, et al.
Publicado: (2021)

Agrin Promotes Non-Small Cell Lung Cancer Progression and Stimulates Regulatory T Cells via Increasing IL-6 Secretion Through PI3K/AKT Pathway
por: Han, Linzhi, et al.
Publicado: (2022)

The prognostic value of tumor mutational burden and immune cell infiltration in esophageal cancer patients with or without radiotherapy
por: Yuan, Cheng, et al.
Publicado: (2020)

Trichosanthin increases Granzyme B penetration into tumor cells by upregulation of CI-MPR on the cell surface
por: Li, Chunman, et al.
Publicado: (2017)

Trichosanthin inhibits cell growth and metastasis by promoting pyroptosis in non-small cell lung cancer
por: Tan, Yan, et al.
Publicado: (2022)

Aptamer-miRNA-212 Conjugate Sensitizes NSCLC Cells to TRAIL
por: Iaboni, Margherita, et al.
Publicado: (2016)

Trichosanthin suppresses the proliferation of glioma cells by inhibiting LGR5 expression and the Wnt/β-catenin signaling pathway
por: MIAO, JUNJIE, et al.
Publicado: (2015)

Establishment of the prognostic index of lung squamous cell carcinoma based on immunogenomic landscape analysis
por: Zhang, Jianguo, et al.
Publicado: (2020)

BRD4 inhibition promotes TRAIL-induced apoptosis by suppressing the transcriptional activity of NF-κB in NSCLC
por: Shi, Liu, et al.
Publicado: (2021)

Metachronous Brain Metastasis in patients with EGFR-mutant NSCLC indicates a worse prognosis
por: Ouyang, Wen, et al.
Publicado: (2020)

A Sixty-Year Research and Development of Trichosanthin, a Ribosome-Inactivating Protein
por: Lu, Jia-Qi, et al.
Publicado: (2022)

Trichosanthin Promotes Anti-Tumor Immunity through Mediating Chemokines and Granzyme B Secretion in Hepatocellular Carcinoma
por: Wang, Kaifang, et al.
Publicado: (2023)

Immunomodulation of NK Cells by Ionizing Radiation
por: Chen, Jiarui, et al.
Publicado: (2020)

Gold nanoparticles enhance TRAIL sensitivity through Drp1-mediated apoptotic and autophagic mitochondrial fission in NSCLC cells
por: Ke, Sunkui, et al.
Publicado: (2017)

Establishment of the Prognostic Index Reflecting Tumor Immune Microenvironment of Lung Adenocarcinoma Based on Metabolism-Related Genes
por: Zhang, Jianguo, et al.
Publicado: (2020)

Gene signature based on B cell predicts clinical outcome of radiotherapy and immunotherapy for patients with lung adenocarcinoma
por: Han, Linzhi, et al.
Publicado: (2020)

Structural and Functional Investigation and Pharmacological Mechanism of Trichosanthin, a Type 1 Ribosome-Inactivating Protein
por: Shi, Wei-Wei, et al.
Publicado: (2018)

Trailing TRAIL Resistance: Novel Targets for TRAIL Sensitization in Cancer Cells
por: Trivedi, Rachana, et al.
Publicado: (2015)

Mapping patterns of metastatic lymph nodes for postoperative radiotherapy in thoracic esophageal squamous cell carcinoma: a recommendation for clinical target volume definition
por: Yu, Jing, et al.
Publicado: (2019)

Trichosanthin enhances the antitumor effect of gemcitabine in non-small cell lung cancer via inhibition of the PI3K/AKT pathway
por: Tuya, Naren, et al.
Publicado: (2017)

Aspirin sensitizes osimertinib‐resistant NSCLC cells in vitro and in vivo via Bim‐dependent apoptosis induction
por: Han, Rui, et al.
Publicado: (2020)

Structures of Eukaryotic Ribosomal Stalk Proteins and Its Complex with Trichosanthin, and Their Implications in Recruiting Ribosome-Inactivating Proteins to the Ribosomes
por: Choi, Andrew K. H., et al.
Publicado: (2015)

Stromal microenvironment promoted infiltration in esophageal adenocarcinoma and squamous cell carcinoma: a multi-cohort gene-based analysis
por: Li, Jiali, et al.
Publicado: (2020)

Gefitinib upregulates death receptor 5 expression to mediate rmhTRAIL-induced apoptosis in Gefitinib-sensitive NSCLC cell line
por: Yan, Dong, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_spishtvhlu3m9sti4sidvqo6ll